• 76974 Citations
  • 106 h-Index
1974 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Aron Goldhirsch is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Breast Neoplasms Medicine & Life Sciences
Tamoxifen Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
letrozole Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Estrogen Receptors Medicine & Life Sciences
Recurrence Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1974 2019

3 Citations (Scopus)

Adjuvant letrozole and tamoxifen alone or sequentially for postmenopausal women with hormone receptor-positive breast cancer: Long-term follow-up of the BiG 1-98 trial

BIG 1-98 Collaborative Group and the International Breast Cancer Study Group, Jan 10 2019, In : Journal of Clinical Oncology. 37, 2, p. 105-114 10 p.

Research output: Contribution to journalArticle

letrozole
Tamoxifen
Hormones
Breast Neoplasms
Disease-Free Survival
12 Citations (Scopus)

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Apr 6 2019, In : The Lancet. 393, 10179, p. 1440-1452 13 p.

Research output: Contribution to journalArticle

Open Access
Meta-Analysis
Breast Neoplasms
Drug Therapy
Appointments and Schedules
Recurrence

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

International Breast Cancer Study Group Trial 23-01, Oct 1 2018, In : The Lancet Oncology. 19, 10, p. 1385-1393 9 p.

Research output: Contribution to journalArticle

Neoplasm Micrometastasis
Dissection
Breast Neoplasms
Disease-Free Survival
cyhalothrin
22 Citations (Scopus)

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

International Breast Cancer Study Group Trial 23-01, Oct 1 2018, In : The Lancet Oncology. 19, 10, p. 1385-1393 9 p.

Research output: Contribution to journalArticle

Neoplasm Micrometastasis
Dissection
Breast Neoplasms
Disease-Free Survival
cyhalothrin
62 Citations (Scopus)

Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis

Conforti, F., Pala, L., Bagnardi, V., De Pas, T., Martinetti, M., Viale, G., Gelber, R. D. & Goldhirsch, A., Jun 1 2018, In : The Lancet Oncology. 19, 6, p. 737-746 10 p.

Research output: Contribution to journalArticle

Immunotherapy
Meta-Analysis
Neoplasms
Survival
Non-Small Cell Lung Carcinoma